Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
NCT ID: NCT00564265
Last Updated: 2011-08-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2008-01-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
NCT04557969
Prognostic Factors Affecting Survival of Gastric GIST
NCT04269941
Gastrointestinal Stromal Tumors (GIST) Registry
NCT00507273
Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors
NCT03601234
Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)
NCT02147145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GIST
GIST from all gastrointestinal origins: esophagus, stomach, duodenum, jejunum, ileum, colon and rectum
Observation
Not applied
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Not applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive immunohistochemistry
Exclusion Criteria
* Patients with GIST operated on but without immunohistochemistry
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cirujanos la Serena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sobelcru Ltda
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo A Beltran, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital de La Serena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital De La Serena
La Serena, Coquimbo Region, Chile
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Revista Chilena de Cirugia, 2011; 63:290-296
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0047-11-07
Identifier Type: -
Identifier Source: secondary_id
HLS-0047-11-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.